Literature DB >> 16622615

Massive pulmonary embolism in a Lebanese patient doubly heterozygous for MTHFR and Factor V Leiden presenting with syncope and treated with tenecteplase.

Hussain Isma'eel1, Ali Taher, Samir Alam, M Samir Arnaout.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 16622615     DOI： 10.1007/s11239-006-4663-0

Source DB:  PubMed          Journal:  J Thromb Thrombolysis        ISSN： 0929-5305            Impact factor:   2.300


× No keyword cloud information.
  22 in total

1.  High prevalence of Factor V Leiden mutation among healthy individuals and patients with deep venous thrombosis in Lebanon: is the eastern Mediterranean region the area of origin of this mutation?

Authors:  A Taher; I Khalil; A Shamseddine; F El-Ahdab; A Bazarbachi
Journal:  Thromb Haemost       Date:  2001-08       Impact factor: 5.249

2.  Safety assessment of single-bolus administration of TNK tissue-plasminogen activator in acute myocardial infarction: the ASSENT-1 trial. The ASSENT-1 Investigators.

Authors:  F Van de Werf; C P Cannon; A Luyten; K Houbracken; C H McCabe; S Berioli; E Bluhmki; H Sarelin; F Wang-Clow; N L Fox; E Braunwald
Journal:  Am Heart J       Date:  1999-05       Impact factor: 4.749

Review 3.  Management of massive pulmonary embolism.

Authors:  Nils Kucher; Samuel Z Goldhaber
Journal:  Circulation       Date:  2005-07-12       Impact factor: 29.690

4.  TNK-tissue plasminogen activator compared with front-loaded alteplase in acute myocardial infarction: results of the TIMI 10B trial. Thrombolysis in Myocardial Infarction (TIMI) 10B Investigators.

Authors:  C P Cannon; C M Gibson; C H McCabe; A A Adgey; M J Schweiger; R F Sequeira; G Grollier; R P Giugliano; M Frey; H S Mueller; R M Steingart; W D Weaver; F Van de Werf; E Braunwald
Journal:  Circulation       Date:  1998 Dec 22-29       Impact factor: 29.690

5.  Out-of-hospital cardiac arrests of non-cardiac origin. Epidemiology and outcome.

Authors:  M Kuisma; A Alaspää
Journal:  Eur Heart J       Date:  1997-07       Impact factor: 29.983

6.  A faster-acting and more potent form of tissue plasminogen activator.

Authors:  B A Keyt; N F Paoni; C J Refino; L Berleau; H Nguyen; A Chow; J Lai; L Peña; C Pater; J Ogez
Journal:  Proc Natl Acad Sci U S A       Date:  1994-04-26       Impact factor: 11.205

Review 7.  Helical CT for the evaluation of acute pulmonary embolism.

Authors:  Smita Patel; Ella A Kazerooni
Journal:  AJR Am J Roentgenol       Date:  2005-07       Impact factor: 3.959

8.  Single-bolus tenecteplase compared with front-loaded alteplase in acute myocardial infarction: the ASSENT-2 double-blind randomised trial.

Authors:  F Van De Werf; J Adgey; D Ardissino; P W Armstrong; P Aylward; G Barbash; A Betriu; A S Binbrek; R Califf; R Diaz; R Fanebust; K Fox; C Granger; J Heikkilä; S Husted; P Jansky; A Langer; E Lupi; A Maseri; J Meyer; J Mlczoch; D Mocceti; D Myburgh; A Oto; E Paolasso; K Pehrsson; R Seabra-Gomes; L Soares-Piegas; D Sùgrue; M Tendera; E Topol; P Toutouzas; A Vahanian; F Verheugt; L Wallentin; H White
Journal:  Lancet       Date:  1999-08-28       Impact factor: 79.321

9.  TNK-tissue plasminogen activator in acute myocardial infarction. Results of the Thrombolysis in Myocardial Infarction (TIMI) 10A dose-ranging trial.

Authors:  C P Cannon; C H McCabe; C M Gibson; M Ghali; R F Sequeira; G R McKendall; J Breed; N B Modi; N L Fox; R P Tracy; T W Love; E Braunwald
Journal:  Circulation       Date:  1997-01-21       Impact factor: 29.690

10.  Differences in the frequency of the C677T mutation in the methylenetetrahydrofolate reductase (MTHFR) gene among the Lebanese population.

Authors:  Wassim Y Almawi; Ramzi R Finan; Hala Tamim; Jocelyn L Daccache; Noha Irani-Hakime
Journal:  Am J Hematol       Date:  2004-05       Impact factor: 10.047
View more
  3 in total

Review 1.  Tenecteplase to treat pulmonary embolism in the emergency department.

Authors:  Jeffrey A Kline; Jackeline Hernandez-Nino; Alan E Jones
Journal:  J Thromb Thrombolysis       Date:  2007-04       Impact factor: 2.300

2.  Genetic thrombophilia in patients with VTE in eastern Mediterranean located tertiary care center; is it time to change the algorithm for thrombophilia work up decision making?

Authors:  H Isma'eel; R El Accaoui; W Shamseddeen; A Taher; S Alam; R Mahfouz; M S Arnaout
Journal:  J Thromb Thrombolysis       Date:  2006-06       Impact factor: 2.300

3.  An unusual presentation of a massive pulmonary embolism with misleading investigation results treated with tenecteplase.

Authors:  David Migneault; Zachary Levine; François de Champlain
Journal:  Case Rep Emerg Med       Date:  2015-02-19
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.